Phase 4 Psoriatic Arthritis Trial, Recruiting NCT07149792 Sponsor: Taichung Veterans General Hospital Condition: Psoriatic Arthritis
Back to Psoriatic Arthritis

Phase 4 Psoriatic Arthritis Trial, Recruiting

NCT07149792
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are generally in good health (healthy volunteer)
  • You have been diagnosed with psoriasis (a skin condition)
  • You have been diagnosed with psoriatic arthritis (a joint condition linked to psoriasis)
  • You are willing to provide a blood sample

Who may not be able to join:

  • You currently have or have a history of cancer
  • You were recently in hospital due to an infection, or you are currently taking antibiotics
  • You have HIV

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 886-4-23592525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Taichung Veterans General Hospital
Registry
ClinicalTrials.gov
Start date
29 July 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

PASI (Psoriasis Area and Severity Index); DAPSA Score - Disease Activity in Psoriatic Arthritis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov